And basically the studies went and asked the physicians like if you get paid more, are you going to vaccinate more
Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
Monotherapy with the once weekly GLP-1 receptor agonist dulaglutide for 12 weeks in Japanese patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomised, double-blind, placebo-controlled study
[26] GLP-1 exerts its metabolic effects through activation of GLP-1 receptors (GLP-1R) distributed throughout multiple organ systems, including the pancreas, brain, gastrointestinal tract, and cardiovascular system
Consumer reviews show mixed results, with many reporting skin irritation and no weight change